Challenges in Implementing Precision Medicine for Ovarian Cancer
Author Information
Author(s): Moffitt Laura R., Karimnia Nazanin, Wilson Amy L., Stephens Andrew N., Ho Gwo-Yaw, Bilandzic Maree
Primary Institution: Hudson Institute of Medical Research
Hypothesis
What are the barriers to implementing precision medicine in ovarian cancer treatment?
Conclusion
The review highlights significant challenges in implementing precision medicine for ovarian cancer, including tumor heterogeneity and limited sample availability.
Supporting Evidence
- Precision medicine has been successful in other cancers but faces unique challenges in ovarian cancer.
- Most genetic alterations in ovarian cancer are not consistently linked to clinical outcomes.
- High-throughput drug screening methods need to better reflect the tumor environment.
Takeaway
This study talks about how doctors are trying to use special tests to find the best treatments for women with ovarian cancer, but there are many problems that make it hard to do this.
Methodology
The review discusses various barriers to precision medicine in ovarian cancer, including issues with tissue sample collection and the need for better screening methods.
Limitations
The review does not provide new experimental data but synthesizes existing literature on the challenges of precision medicine in ovarian cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website